GET THE APP

Mycobacterial Diseases

Mycobacterial Diseases
Open Access

ISSN: 2161-1068

Opinion Article - (2023)Volume 13, Issue 1

Treatment and Prevention of Mycobacterial Toxicity

Nishmi Gunasingam*
 
*Correspondence: Nishmi Gunasingam, Department of Gastroenterology, St Vincent’s Hospital, Sydney, Australia, Email:

Author info »

Description

Mycobacterial toxicity refers to the harmful effects that are caused by certain species of bacteria known as mycobacteria. These bacteria are known for their ability to cause a wide range of diseases in humans, ranging from mild skin infections to lifethreatening illnesses such as tuberculosis. Mycobacteria are found in many different environments, including soil, water, and air. They can be present in both natural and man-made environments, and can cause infections in both animals and humans. The various aspects of mycobacterial toxicity and the ways in which it can be prevented and treated.

Mycobacterial toxicity and health

The most well-known disease caused by mycobacteria is tuberculosis (TB). This disease is caused by the bacterium Mycobacterium tuberculosis, which is primarily spread through the air. When a person with TB coughs or sneezes, they release tiny droplets containing the bacteria into the air, which can then be inhaled by others. TB is a serious disease that can affect many different parts of the body, including the lungs, bones, and brain. It can cause a range of symptoms, including coughing, fever, weight loss, and fatigue. In some cases, TB can be fatal, particularly if it is not treated promptly and effectively. Other mycobacterial diseases include leprosy, Buruli ulcer, and Non-Tuberculous Mycobacterial Infections (NTMI). Leprosy is caused by the bacterium Mycobacterium leprae and primarily affects the skin, nerves, and respiratory system. NTM infections are caused by a variety of mycobacteria and can cause a range of symptoms, depending on the specific bacterium involved.

Prevention of mycobacterial toxicity

Preventing mycobacterial toxicity requires a combination of strategies, including good hygiene practices, vaccination, and environmental control measures. Good hygiene practices include washing your hands regularly, covering your mouth when you cough or sneeze, and avoiding close contact with people who are sick.

Vaccination is an important way to prevent TB, and the Bacilli Calmette-Guérin (BCG) vaccine is currently the only vaccine available for this disease. The BCG vaccine is recommended for infants and children in many countries, particularly those with a high incidence of TB.

Environmental control measures are also important for preventing mycobacterial toxicity. These measures include ensuring that water sources are clean and free from contamination, maintaining good ventilation in buildings, and taking appropriate precautions when working with animals that may carry mycobacteria.

Treatment of mycobacterial toxicity

The treatment of mycobacterial toxicity depends on the specific disease involved. For TB, a combination of antibiotics is typically used for several months to effectively kill the bacteria. Treatment for leprosy and Buruli ulcer also involves a combination of antibiotics, although the specific drugs used may differ. NTM infections are typically treated with a combination of antibiotics as well, but the treatment course can be longer and more complex than for TB. In some cases, surgical removal of infected tissue may also be necessary.

Conclusion

In addition to antibiotics, other treatments may be necessary to manage the symptoms of mycobacterial diseases. For example, pain relief medication may be necessary for individuals with leprosy who experience nerve damage, while wound care and skin grafting may be necessary for individuals with Buruli ulcer. Buruli ulcer is caused by the bacterium Mycobacterium ulcerans and can cause large, open sores on the skin.

Author Info

Nishmi Gunasingam*
 
Department of Gastroenterology, St Vincent’s Hospital, Sydney, Australia
 

Citation: Gunasingam N (2023) Treatment and Prevention of Mycobacterial Toxicity. Mycobact Dis.13:319.

Received: 02-Jan-2023, Manuscript No. MDTL-23-23486; Editor assigned: 05-Jan-2023, Pre QC No. MDTL-23-23486 (PQ); Reviewed: 19-Jan-2023, QC No. MDTL-23-23486; Revised: 26-Jan-2023, Manuscript No. MDTL-23-23486 (R); Published: 02-Feb-2023 , DOI: 10.35248/2161-1068.23.13.319

Copyright: © 2023 Gunasingam N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top